Applied BioCode (6598) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.029x

Based on the latest financial reports, Applied BioCode (6598) has a cash flow conversion efficiency ratio of -0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-19.88 Million ≈ $-626.20K USD) by net assets (NT$687.57 Million ≈ $21.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 6598 market cap for the company's overall valuation and market capitalisation.

Applied BioCode - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Applied BioCode's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Applied BioCode Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Applied BioCode ranked by their cash flow conversion efficiency. Explore Applied BioCode earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Raonsecure Co. Ltd KQ:042510	-0.015x
IDREAMSKY TE+H. DL-0001 F:08IA	N/A
CareCloud, Inc. NASDAQ:CCLD	0.406x
EDAG Engineering Group AG XETRA:ED4	0.052x
Empress Royalty Corp V:EMPR	0.125x
Taiwan Takisawa Technology Co Ltd TWO:6609	-0.022x
Martin Midstream Partners LP NASDAQ:MMLP	0.015x
Purit Co. Ltd. KQ:445180	0.022x

Annual Cash Flow Conversion Efficiency for Applied BioCode (2013–2024)

The table below shows the annual cash flow conversion efficiency of Applied BioCode from 2013 to 2024. View Applied BioCode stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$878.83 Million ≈ $27.69 Million	NT$-207.74 Million ≈ $-6.54 Million	-0.236x	+23.82%
2023-12-31	NT$660.99 Million ≈ $20.82 Million	NT$-205.09 Million ≈ $-6.46 Million	-0.310x	-273.58%
2022-12-31	NT$816.07 Million ≈ $25.71 Million	NT$145.87 Million ≈ $4.60 Million	0.179x	+206.34%
2021-12-31	NT$902.96 Million ≈ $28.45 Million	NT$-151.77 Million ≈ $-4.78 Million	-0.168x	-24.51%
2020-12-31	NT$1.09 Billion ≈ $34.25 Million	NT$-146.74 Million ≈ $-4.62 Million	-0.135x	+77.17%
2019-12-31	NT$530.65 Million ≈ $16.72 Million	NT$-313.84 Million ≈ $-9.89 Million	-0.591x	+10.74%
2018-12-31	NT$432.73 Million ≈ $13.63 Million	NT$-286.71 Million ≈ $-9.03 Million	-0.663x	+26.82%
2017-12-31	NT$276.52 Million ≈ $8.71 Million	NT$-250.36 Million ≈ $-7.89 Million	-0.905x	+13.77%
2016-12-31	NT$427.60 Million ≈ $13.47 Million	NT$-448.96 Million ≈ $-14.14 Million	-1.050x	-35.65%
2015-12-31	NT$270.32 Million ≈ $8.52 Million	NT$-209.24 Million ≈ $-6.59 Million	-0.774x	-89.71%
2014-12-31	NT$315.69 Million ≈ $9.95 Million	NT$-128.80 Million ≈ $-4.06 Million	-0.408x	+24.14%
2013-12-31	NT$170.93 Million ≈ $5.39 Million	NT$-91.93 Million ≈ $-2.90 Million	-0.538x	--

About Applied BioCode

TW:6598 Taiwan Medical Devices

Market Cap

$88.74 Million

NT$2.82 Billion TWD

Market Cap Rank

#19711 Global

#1128 in Taiwan

Share Price

NT$27.40

Change (1 day)

+0.92%

52-Week Range

NT$20.55 - NT$31.50

All Time High

NT$177.50